After this virtual tumor board, the participants will be able to: 

• Understand the importance of multidisciplinary treatment for patients with de novo metastatic breast cancer (dnMBC).
• Apply the latest literature on the local-regional management of the primary tumor for patients with dnMBC.
• Identify when local-regional management of the primary tumor may be considered for select patients with dnMBC.
• Define the potential risks and benefits of local-regional therapy of the primary tumor for patients with dnMBC.

Mehra Golshan, MD, MBA, Smilow Cancer Hospital at Yale-New Haven

Atilla Soran, MD, MPH, FACS, University of Pittsburgh

Mariana Chavez Mac Gregor, MD, MSC, MD Anderson Cancer Center